Itochu Subsidiary A2 Healthcare Expands Post-Marketing Drug Development with PharField Acquisition

Reuters
2025.10.28 06:37
portai
I'm PortAI, I can summarize articles.

Itochu Corporation's subsidiary, A2 Healthcare, is acquiring PharField Corporation to enhance its post-marketing drug development services. A2 Healthcare focuses on supporting pharmaceutical companies with clinical trials and post-marketing surveillance, thereby strengthening Itochu's business in this sector.

Itochu Corporation announced that its wholly owned subsidiary, A2 Healthcare Corporation, will take over the operations of PharField Corporation, strengthening Itochu’s entrusted businesses in post-marketing drug development. A2 Healthcare specializes in supporting domestic and overseas pharmaceutical companies with clinical trials and post-marketing surveillance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Itochu Corporation published the original content used to generate this news brief on October 28, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.